Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Arrhythmogenic Risk in Congenital Heart Patients: the PRECISION Study

NCT04768634 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT04768634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04768634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Arrhythmogenic Risk in Congenital Heart Patients: the PRECISION Study
Lead sponsor
Boston Children's Hospital
Phase
Not applicable
Overall status
Terminated
Start date
March 23, 2021
Completion date
February 6, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia in children, congenital heart disease